InfuSystem Q3 revenue $31.9M (+17% YoY), net income up 56%, raises FY 2023 guidance

InfuSystem Holdings, Inc

2023-Q3 EPS reported $0.04 revenue$94,014,000

Net revenues $31.9M (+17% YoY); net income $0.7M ($0.03 diluted EPS) vs $0.4M prior year.
Adjusted EBITDA $6.2M (+11% YoY); FY 2023 net revenue growth guidance raised to >11% (from >10%).
Patient Services revenue $19.3M (+11%), Device Solutions $12.6M (+27%); gross margin fell to 50.9% from 59.5%.
Operating income increased 80%; record revenue for seventh consecutive quarter.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

InfuSystem Holdings, Inc reported third quarter ended September 30, 2023 results: revenue $31.9 million, net income $0.7 million, or $0.03 per diluted share, EPS $0.03 per diluted share. Guidance raised.

Period: third quarter ended September 30, 2023
Revenue: $31.9 million
Net income: $0.7 million, or $0.03 per diluted share
EPS: $0.03 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

InfuSystem Reports Third Quarter 2023 Financial Results Record Net Revenues of $31.9 million Representing 17% Growth from the Prior Year

View on SEC.gov

50 earnings releases filed in the last 30 days. Browse all earnings releases →

InfuSystem Holdings, Inc filing history →

Source: SEC EDGAR

accession 0001628280-23-037159

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.